Insider Shareholders with Direct Ownership of Structure Therapeutics Inc. (GPCR)
This section provides a comprehensive overview of the insiders with direct ownership of Structure Therapeutics Inc. (GPCR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Structure Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jun Yoon
CHIEF FINANCIAL OFFICER |
229,635 | 0 | 1,293,299 | 2 |
Mar 15, 2025
Added 11.63%
|
|
Raymond C Stevens
CHIEF EXECUTIVE OFFICER |
625,014 | 555,000 | 1,133,678 | 4 |
Mar 15, 2025
Added 23.09%
|
|
Crespo Blas Coll
Chief Medical Officer |
207,588 | 0 | 219,588 | 2 |
Mar 15, 2025
Added 34.76%
|
|
Xichen Lin
CHIEF SCIENTIFIC OFFICER |
272,736 | 106,200 | 166,536 | 4 |
Mar 15, 2025
Added 32.68%
|
|
Ashley Hall
Chief Development Officer |
118,338 | 0 | 118,338 | 2 |
Mar 15, 2025
Added 30.14%
|
|
Yingli Ma
CHIEF TECHNOLOGY OFFICER |
100,539 | 0 | 100,539 | 2 |
Mar 15, 2025
Added 38.83%
|
|
Mark Allen Bach
CHIEF MEDICAL OFFICER |
26,235 | 0 | 26,235 | 1 |
Mar 15, 2024
Added 50.0%
|
|
Bvf Partners L P
> 10% Shareholder |
0 | 7,410,518 | 0 | 1 |
May 10, 2023
Reduced 100.0%
|